MENU
+Compare
EKTAY
Stock ticker: OTC
AS OF
Jul 3 closing price
Price
$5.19
Change
+$0.02 (+0.39%)
Capitalization
3.09B

EKTAY Elekta AB Forecast, Technical & Fundamental Analysis

Sweden-based Elekta develops, manufactures, and distributes treatment planning systems for neurosurgery and radiotherapy, including stereotactic radiosurgery and brachytherapy... Show more

EKTAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for EKTAY with price predictions
Jul 03, 2025

EKTAY in downward trend: 10-day moving average crossed below 50-day moving average on June 18, 2025

The 10-day moving average for EKTAY crossed bearishly below the 50-day moving average on June 18, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where EKTAY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for EKTAY entered a downward trend on July 02, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 58 cases where EKTAY's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on July 02, 2025. You may want to consider a long position or call options on EKTAY as a result. In of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for EKTAY just turned positive on June 26, 2025. Looking at past instances where EKTAY's MACD turned positive, the stock continued to rise in of 45 cases over the following month. The odds of a continued upward trend are .

EKTAY moved above its 50-day moving average on July 02, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where EKTAY advanced for three days, in of 298 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.298) is normal, around the industry mean (24.348). P/E Ratio (34.014) is within average values for comparable stocks, (77.706). Projected Growth (PEG Ratio) (0.886) is also within normal values, averaging (5.667). Dividend Yield (0.028) settles around the average of (0.018) among similar stocks. P/S Ratio (1.904) is also within normal values, averaging (42.660).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. EKTAY’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. EKTAY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.

View a ticker or compare two or three
EKTAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published Dividends

EKTAY paid dividends on March 27, 2025

Elekta AB EKTAY Stock Dividends
А dividend of $0.12 per share was paid with a record date of March 27, 2025, and an ex-dividend date of March 07, 2025. Read more...
A.I. Advisor
published General Information

General Information

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
N/A
Address
Kungstensgatan 18
Phone
+46 858725400
Employees
4700
Web
https://www.elekta.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PRIAX30.83N/A
N/A
Principal Glb Emerging Markets A
PMBMX43.20N/A
N/A
Principal MidCap R3
GNSRX31.72N/A
N/A
abrdn US Small Cap Equity R
BGLTX37.44N/A
N/A
Baillie Gifford Long Term Global Gr 2
TSLTX4.90N/A
N/A
Transamerica Small Cap Value I3

EKTAY and Stocks

Correlation & Price change

A.I.dvisor tells us that EKTAY and SAUHY have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EKTAY and SAUHY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EKTAY
1D Price
Change %
EKTAY100%
+0.39%
SAUHY - EKTAY
31%
Poorly correlated
-0.89%
SMMNY - EKTAY
29%
Poorly correlated
-1.31%
PHG - EKTAY
29%
Poorly correlated
-1.43%
GNGBY - EKTAY
26%
Poorly correlated
-0.98%
NEOG - EKTAY
26%
Poorly correlated
+1.91%
More